258 related articles for article (PubMed ID: 31099754)
1. KLK3/PSA and cathepsin D activate VEGF-C and VEGF-D.
Jha SK; Rauniyar K; Chronowska E; Mattonet K; Maina EW; Koistinen H; Stenman UH; Alitalo K; Jeltsch M
Elife; 2019 May; 8():. PubMed ID: 31099754
[TBL] [Abstract][Full Text] [Related]
2. KLK3 in the Regulation of Angiogenesis-Tumorigenic or Not?
Koistinen H; Künnapuu J; Jeltsch M
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948344
[TBL] [Abstract][Full Text] [Related]
3. Differential Receptor Binding and Regulatory Mechanisms for the Lymphangiogenic Growth Factors Vascular Endothelial Growth Factor (VEGF)-C and -D.
Davydova N; Harris NC; Roufail S; Paquet-Fifield S; Ishaq M; Streltsov VA; Williams SP; Karnezis T; Stacker SA; Achen MG
J Biol Chem; 2016 Dec; 291(53):27265-27278. PubMed ID: 27852824
[TBL] [Abstract][Full Text] [Related]
4. Proteolytic Cleavages in the VEGF Family: Generating Diversity among Angiogenic VEGFs, Essential for the Activation of Lymphangiogenic VEGFs.
Künnapuu J; Bokharaie H; Jeltsch M
Biology (Basel); 2021 Feb; 10(2):. PubMed ID: 33672235
[TBL] [Abstract][Full Text] [Related]
5. Structural determinants of vascular endothelial growth factor-D receptor binding and specificity.
Leppänen VM; Jeltsch M; Anisimov A; Tvorogov D; Aho K; Kalkkinen N; Toivanen P; Ylä-Herttuala S; Ballmer-Hofer K; Alitalo K
Blood; 2011 Feb; 117(5):1507-15. PubMed ID: 21148085
[TBL] [Abstract][Full Text] [Related]
6. Major role of human KLK14 in seminal clot liquefaction.
Emami N; Deperthes D; Malm J; Diamandis EP
J Biol Chem; 2008 Jul; 283(28):19561-9. PubMed ID: 18482984
[TBL] [Abstract][Full Text] [Related]
7. CCBE1 enhances lymphangiogenesis via A disintegrin and metalloprotease with thrombospondin motifs-3-mediated vascular endothelial growth factor-C activation.
Jeltsch M; Jha SK; Tvorogov D; Anisimov A; Leppänen VM; Holopainen T; Kivelä R; Ortega S; Kärpanen T; Alitalo K
Circulation; 2014 May; 129(19):1962-71. PubMed ID: 24552833
[TBL] [Abstract][Full Text] [Related]
8. Vascular endothelial growth factor (VEGF)-C, VEGF-D, VEGFR-3 and D2-40 expressions in primary breast cancer: Association with lymph node metastasis.
Eroğlu A; Ersöz C; Karasoy D; Sak S
Adv Clin Exp Med; 2017; 26(2):245-249. PubMed ID: 28791841
[TBL] [Abstract][Full Text] [Related]
9. Proteolytic activation defines distinct lymphangiogenic mechanisms for VEGFC and VEGFD.
Bui HM; Enis D; Robciuc MR; Nurmi HJ; Cohen J; Chen M; Yang Y; Dhillon V; Johnson K; Zhang H; Kirkpatrick R; Traxler E; Anisimov A; Alitalo K; Kahn ML
J Clin Invest; 2016 Jun; 126(6):2167-80. PubMed ID: 27159393
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathological and prognostic significance of vascular endothelial growth factors (VEGF)-C and -D and VEGF receptor 3 in invasive breast carcinoma.
Mylona E; Alexandrou P; Mpakali A; Giannopoulou I; Liapis G; Markaki S; Keramopoulos A; Nakopoulou L
Eur J Surg Oncol; 2007 Apr; 33(3):294-300. PubMed ID: 17129704
[TBL] [Abstract][Full Text] [Related]
11. Genetic variation in KLK2 and KLK3 is associated with concentrations of hK2 and PSA in serum and seminal plasma in young men.
Sävblom C; Halldén C; Cronin AM; Säll T; Savage C; Vertosick EA; Klein RJ; Giwercman A; Lilja H
Clin Chem; 2014 Mar; 60(3):490-9. PubMed ID: 24270797
[TBL] [Abstract][Full Text] [Related]
12. Endothelin-1 cooperates with hypoxia to induce vascular-like structures through vascular endothelial growth factor-C, -D and -A in lymphatic endothelial cells.
Garrafa E; Caprara V; Di Castro V; Rosanò L; Bagnato A; Spinella F
Life Sci; 2012 Oct; 91(13-14):638-43. PubMed ID: 22552325
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the precursor of prostate-specific antigen. Activation by trypsin and by human glandular kallikrein.
Takayama TK; Fujikawa K; Davie EW
J Biol Chem; 1997 Aug; 272(34):21582-8. PubMed ID: 9261179
[TBL] [Abstract][Full Text] [Related]
14. Virtual Screening of Small Drug-Like Compounds Stimulating the Enzymatic Activity of Kallikrein-Related Peptidase 3 (KLK3).
Ylikangas H; Mattsson JM; Stenman UH; Koistinen H; Poso A; Lahtela-Kakkonen M
ChemMedChem; 2016 Sep; 11(18):2043-9. PubMed ID: 27465435
[TBL] [Abstract][Full Text] [Related]
15. The tyrosine kinase inhibitor cediranib blocks ligand-induced vascular endothelial growth factor receptor-3 activity and lymphangiogenesis.
Heckman CA; Holopainen T; Wirzenius M; Keskitalo S; Jeltsch M; Ylä-Herttuala S; Wedge SR; Jürgensmeier JM; Alitalo K
Cancer Res; 2008 Jun; 68(12):4754-62. PubMed ID: 18559522
[TBL] [Abstract][Full Text] [Related]
16. Differential expression of VEGF ligands and receptors in prostate cancer.
Woollard DJ; Opeskin K; Coso S; Wu D; Baldwin ME; Williams ED
Prostate; 2013 May; 73(6):563-72. PubMed ID: 23038639
[TBL] [Abstract][Full Text] [Related]
17. VEGF-C, VEGF-D and VEGFR-3 expression in peripheral neuroblastic tumours.
Ramani P; Nash R; Radevsky L; Patel A; Luckett M; Rogers C
Histopathology; 2012 Dec; 61(6):1006-16. PubMed ID: 22804730
[TBL] [Abstract][Full Text] [Related]
18. Seminal fluid characterization for male fertility and prostate cancer: kallikrein-related serine proteases and whole proteome approaches.
Veveris-Lowe TL; Kruger SJ; Walsh T; Gardiner RA; Clements JA
Semin Thromb Hemost; 2007 Feb; 33(1):87-99. PubMed ID: 17253195
[TBL] [Abstract][Full Text] [Related]
19. The discovery of compounds that stimulate the activity of kallikrein-related peptidase 3 (KLK3).
Härkönen HH; Mattsson JM; Määttä JA; Stenman UH; Koistinen H; Matero S; Windshügel B; Poso A; Lahtela-Kakkonen M
ChemMedChem; 2011 Dec; 6(12):2170-8. PubMed ID: 21953896
[TBL] [Abstract][Full Text] [Related]
20. Lymphangiogenesis in aortic valve stenosis--novel regulatory roles for valvular myofibroblasts and mast cells.
Syväranta S; Helske S; Lappalainen J; Kupari M; Kovanen PT
Atherosclerosis; 2012 Apr; 221(2):366-74. PubMed ID: 22281299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
